Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Inventory Average (2016 - 2025)

Historic Inventory Average for Amicus Therapeutics (FOLD) over the last 10 years, with Q3 2025 value amounting to $166.4 million.

  • Amicus Therapeutics' Inventory Average rose 6922.93% to $166.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.4 million, marking a year-over-year increase of 6922.93%. This contributed to the annual value of $89.2 million for FY2024, which is 11371.54% up from last year.
  • According to the latest figures from Q3 2025, Amicus Therapeutics' Inventory Average is $166.4 million, which was up 6922.93% from $143.6 million recorded in Q2 2025.
  • Amicus Therapeutics' Inventory Average's 5-year high stood at $166.4 million during Q3 2025, with a 5-year trough of $17.1 million in Q3 2022.
  • For the 5-year period, Amicus Therapeutics' Inventory Average averaged around $59.5 million, with its median value being $39.2 million (2023).
  • Per our database at Business Quant, Amicus Therapeutics' Inventory Average plummeted by 2601.28% in 2022 and then surged by 21717.08% in 2023.
  • Quarter analysis of 5 years shows Amicus Therapeutics' Inventory Average stood at $24.4 million in 2021, then fell by 24.14% to $18.5 million in 2022, then soared by 214.47% to $58.3 million in 2023, then surged by 100.73% to $117.1 million in 2024, then surged by 42.15% to $166.4 million in 2025.
  • Its Inventory Average stands at $166.4 million for Q3 2025, versus $143.6 million for Q2 2025 and $125.6 million for Q1 2025.